Translating non-clinical proof-of-concept data into paediatric development decisions: the case of HER2-targeting antibody-drug conjugates

EJC Paediatric Oncology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles